ACHL

Achilles Therapeutics plc American Depositary Shares
ACHL

Overview Fund Activity
Delisted

ACHL was delisted on the 20th of March, 2025.

Back to rankings

28 hedge funds and large institutions have $58.3M invested in Achilles Therapeutics plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
9
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
$4.76M
2
KHCM
Kettle Hill Capital Management
New York
$844K
3
FA
Forefront Analytics
Pennsylvania
$72K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
$39K
5
SEI Investments
SEI Investments
Pennsylvania
$88K

Top Sellers

1
WP
Woodline Partners
California
$0
2
Citadel Advisors
Citadel Advisors
Florida
$0
3
BlackRock
BlackRock
New York
$572K
4
Renaissance Technologies
Renaissance Technologies
New York
$183K
5
Bank of America
Bank of America
North Carolina
$21K
Name Holding Trade Value Shares
Change 		Shares
Change %
CUAMC
26
China Universal Asset Management Company
China
$1K +$1K +366 New
WP
27
Woodline Partners
California
– -$588K -233,180 Closed
Citadel Advisors
28
Citadel Advisors
Florida
– -$69K -27,468 Closed
1
2